MLMyung Jin Lee

Myung Jin Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Myung Jin Lee has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mineral Trioxide Aggregate as a Multicomponent Interfacial Layer for Dendrite-Free Lithium Metal Deposition

    by Myung Jin Lee, Maria Jose Lopez Mansueti, Jenny Nazmin Zaman, Ju Ye Kim, Mihye Wu

    The practical application of Li-metal batteries is hindered by nonuniform Li deposition and continuous degradation of the solid electrolyte interphase (SEI). Here, commercially available mineral trioxide aggregate (MTA), a multicomponent calcium silicate-based dental material, was repurposed as a mineral-derived interfacial modifier for Cu current collectors. Structural and compositional analyses confirmed that MTA consists of agglomerated nanoscale particles containing multiple calcium silicate-based and other inorganic phases. Ex-situ SEM images show that the MTA layer promoted spatially distributed Li nucleation and more continuous and compact Li deposition, whereas bare Cu exhibited localized nucleation followed by nonuniform and dendritic growth. More importantly, XPS depth profiling revealed pronounced F enrichment throughout the interphase on MTA-coated Cu, including a persistent inorganic fluoride contribution, demonstrating the formation of an F-rich SEI at the MTA-modified interface. The combined regulation of Li deposition morphology and interphase chemistry suppressed localized dendritic growth and improved Li plating/stripping reversibility. At the current density of 0.5 mA cm‐2 for 1.0 mAh cm‐2, MTA-coated Cu maintained a Coulombic efficiency above 95% for 250 cycles, whereas bare Cu exhibited rapid deterioration after approximately 80 cycles. Improved cycling performance was also obtained at higher current densities of 1.0 and 2.0 mA cm‐2. These findings demonstrate that readily available multicomponent mineral materials can serve as dual physical and chemical interfacial modifiers for simultaneously regulating Li growth and SEI formation in Li-metal batteries.

  • Open Access

    Difference in light transmittance and depth of cure of flowable composite depending on tooth thickness: an in vitro experimental study

    by Seong-Pyo Bae, Myung-Jin Lee, Kyung-San Min, Mi-Kyung Yu, Kwang-Won Lee

    Objectives: This study aimed to quantify light attenuation through varying tooth thicknesses and its impact on the depth of cure of composite resin.Methods: Twenty extracted premolars were used to create enamel-dentin discs that were sanded progressively in 0.5 mm increments from 2.5 mm to 0.5 mm. Light irradiance was measured with and without tooth specimens to evaluate light transmittance. Resin was cured beneath different thicknesses, and the depth of cure was assessed using the Vickers hardness test.Results: The results demonstrated that light transmittance significantly decreased as tooth thickness increased (p < 0.01), leading to reduced resin polymerization. In the 2.0-mm and 2.5-mm tooth thickness groups, the depth of cure was significantly lower than in the control group without tooth specimens (p < 0.05).Conclusions: Ultimately, for tooth structures exceeding 2 mm, self-cure or dual-cure resin polymerization is thought to be more efficient than light polymerization.

  • Open Access

    First‐In‐Human Study of Safety, Tolerability, Efficacy, and Pharmacokinetics of CPNE7‐Derived Peptide (Selcopintide) for Dentin Hypersensitivity

    by Myung Jin Lee, Yoon Seon Lee, Joo‐Cheol Park, Hyun Chul Kim, So Hyun Park, Howard Lee, Won Jun Shon

    Dentin hypersensitivity is characterized by transient, sharp pain resulting from dentin exposure due to enamel or cementum loss. Current treatments, which primarily focus on superficial tubule occlusion or nerve desensitization, provide only temporary relief. Copine7 (CPNE7) induces odontoblast differentiation and physiologic dentin regeneration, enabling biological dentin sealing and presenting a novel therapeutic approach. This study reports the first‐in‐human results of a randomized, double‐blind, dose‐escalation phase 1/2a clinical trial evaluating the safety, tolerability, preliminary efficacy, and pharmacokinetics of the CPNE7‐derived functional peptide (selcopintide) in patients with dentin hypersensitivity. In Part A (Single Ascending Dose, SAD), 24 participants received a single topical application of selcopintide at ascending doses (2.5, 5, and 10 μg/tooth) in a 6:2 randomization ratio (treatment: placebo). In Part B (Multiple Ascending Dose, MAD), 16 participants received three topical applications (5 and 10 μg/tooth) over 15 days (day 1, 8, and 15; visits 2–4) with the same randomization ratio. Efficacy endpoints were assessed by changes in cold water, evaporative air, and tactile sensitivity. In Part B, the 10 μg selcopintide group demonstrated statistically significant reductions from the baseline across all three measures (p < 0.05), with a mean decrease of −23.2 ± 19.4 mm in VAS, the primary efficacy endpoint. All doses were well tolerated, with no serious adverse events and no detectable systemic absorption of selcopintide. These findings support the safety, tolerability, and preliminary efficacy of selcopintide as a novel therapeutic candidate for the treatment of dentin hypersensitivity.